Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Lab ; 70(3)2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38469789

RESUMEN

BACKGROUND: There is a need for accurate and rapid biomarkers for the early diagnosis of diabetic nephropathy (DN). We aimed to study the accuracy of urinary neutrophil gelatinase-associated lipocalin (uNGAL), urinary kidney injury molecule-1 (uKIM-1), and blood NGAL (bNGAL) in type 2 diabetics as biomarkers for diagnosis of DN. METHODS: The study was a retrospective case-control study that included 30 control subjects, 40 diabetics with normo-albuminuria < 30 mg/g and eGFR > 60 mL/minute/1.73 m2, and 30 diabetics with albuminuria > 30mg/g and eGFR < 60mL/minute/1.73 m2. Blood and urine samples were obtained to determine levels of bNGAL, uNAGAL, and uKIM1. RESULTS: There was a significant increase in bNGAL, uNGAL, uKIM 1, uNGAL/creatinine and uKIM 1/creatinine among diabetics with albuminuria compared to diabetics with normoalbuminuria and normal control (p < 0.001 for all markers). For diagnosis of early DN, both bNGAL and uKIM 1 had sensitivity and specificity of 100% for each at cutoff values of 322.5 pg/mL and 74.25 ng/mL, respectively. uNGAL had a sensitivity of 97.5% and a spec-ificity of 100% at a cutoff point of 565 ng/mL. uKIM1/creatinine at a cutoff of 51.2 had a sensitivity of 100% and specificity of 100%. CONCLUSIONS: The present study highlights the accuracy of urinary KIM1 and NGAL and blood NGAL as biomarkers for the diagnosis of nephropathy in the early stage of diabetic nephropathy. There were positive correlations with kidney function tests creatinine, blood urea nitrogen, and the presence of albuminuria.


Asunto(s)
Diabetes Mellitus Tipo 2 , Nefropatías Diabéticas , Humanos , Lipocalina 2/orina , Nefropatías Diabéticas/diagnóstico , Nefropatías Diabéticas/orina , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/orina , Creatinina , Estudios de Casos y Controles , Albuminuria/diagnóstico , Albuminuria/orina , Estudios Retrospectivos , Biomarcadores , Riñón
2.
Artículo en Inglés | MEDLINE | ID: mdl-32026790

RESUMEN

BACKGROUND: There is a need for rapid and accurate diagnostic biomarker for diagnosis of Salmonella fever. AIMS: The aim of the present study was to assess the importance of procalcitonin (PCT), Soluble Triggering Receptors expressed on Myeloid Cells 1 (sTREM1) and C- reactive protein (CRP) in the diagnosis of enteric fever with positive blood culture for S.typhi. METHODS: Blood samples were withdrawn from 200 patients with suspected enteric fever and subjected for the determination of CRP, PCT and sTREM-1. RESULTS: The sensitivity and specificity for PCT cut off were 97.7% & 82.5%, for CRP the sensitivity and specificity were 95.3% and 77% and for s-TREM-1 the sensitivity and specificity were 95.3% & 77%. CONCLUSION: S-TREM-1 may be considered as a novel biomarker for the diagnosis of enteric fever with good sensitivity and specificity.


Asunto(s)
Receptor Activador Expresado en Células Mieloides 1/biosíntesis , Receptor Activador Expresado en Células Mieloides 1/sangre , Fiebre Tifoidea/sangre , Fiebre Tifoidea/diagnóstico , Adulto , Biomarcadores/sangre , Estudios Transversales , Femenino , Expresión Génica , Humanos , Masculino , Polipéptido alfa Relacionado con Calcitonina/biosíntesis , Polipéptido alfa Relacionado con Calcitonina/sangre , Polipéptido alfa Relacionado con Calcitonina/genética , Salmonella typhi/genética , Salmonella typhi/aislamiento & purificación , Receptor Activador Expresado en Células Mieloides 1/genética , Fiebre Tifoidea/genética
3.
Clin Lab ; 66(1)2020 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-32013352

RESUMEN

BACKGROUND: Streptococcus pneumoniae (S. pneumoniae) is a commensal bacterium that normally colonizes the human nasopharyngeal cavity. Once disseminated, it can cause several diseases, ranging from non-invasive infections such as acute otitis media and sinusitis through to invasive infections with higher mortality. Antibiotic resistance among S. pneumoniae has increased dramatically and penicillin-resistant strains have spread worldwide with pneumococcus also being resistant to other types of antibiotics like erythromycin, tetracycline, and chloram-phenicol. The aim of the present study was to study the susceptibility of the isolated strains to ß-lactam and other antibiotics from different classes and to determine the prevalence of ß-lactam resistance genes among S. pneumoniae clinical isolates. METHODS: From a total of 178 sputum samples, isolates identified by standard microbiological method as S. pneu-moniae were subjected to antibiotic susceptibility tests to ß-lactam and non ß-lactam antimicrobial agents by disk diffusion method. Biofilm formation was detected by microtitration plate and the resistance genotype was also determined using multiplex PCR technique with primers designed for PBP genes. RESULTS: Out of 178 sputum samples, sixty isolates were recovered as Streptococcus pneumoniae. Most of isolates were multidrug-resistant (MDR) possessing a high (> 0.2) multiple antibiotic resistance index (MAR) value. Biofilm formation ability of isolates were strong, moderate, weak, and none, accounting for 21.67%, 45%, 25%, and 8.33% biofilm formers, respectively, and it was found that pbp1a, pbp2b, and pbp2x were present in 33 (55%), 25 (41.7%), and 45 (75%) of isolates, respectively. CONCLUSIONS: Streptococcus pneumoniae clinical isolates have an alteration in PBP resistance genes in response to ß-lactam therapy which subsequently lead to increased MDR phenomena among these clinically important pathogens. These findings necessitate continuous monitoring of antimicrobial resistance to guide the empirical treatment of pneumococcal disease, as well as to encourage reflections to support public immunizations strategies.


Asunto(s)
Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/genética , Resistencia betalactámica/genética , Antibacterianos/farmacología , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple/genética , Humanos , Pruebas de Sensibilidad Microbiana , Faringitis/microbiología , Reacción en Cadena de la Polimerasa , Esputo/microbiología , Streptococcus pneumoniae/patogenicidad
4.
Eur J Gastroenterol Hepatol ; 31(6): 716-722, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30870221

RESUMEN

BACKGROUND: Occult hepatitis B virus infection (OBI) frequently occurs in patients with chronic hepatitis C (CHC) infection, but the influence of OBI on CHC outcome is still uncertain. The aim of the present study was to clarify the clinical and pathological characteristics of OBI in CHC-related hepatocellular carcinoma (HCC). PATIENTS AND METHODS: DNA was obtained from serum and tumor tissue of patients with hepatitis C virus (HCV)-related HCC with negative HBsAg and from patients with HCV-related liver cirrhosis. HBV-DNA was detected using qPCR. Clinicopathological features were compared between patients with HCC with and without OBI. RESULTS: On the basis of positive serum and tissue HBV-DNA typing, the overall frequency of OBI was 50% in patients with HCV-related HCC. HBV genotype D was the most dominant, constituting 35.3% of HCC cases. Almost 80% of patients with OBI had anti-HBc, whereas 20% of patients had no serological markers. Tissue HBV-DNA showed significant association with positive serum HBV-DNA, anti-HBc, and genotype D. There were no clinical differences between patients with HCC with and without OBI; however, patients with OBI tended to be younger. HCC cases with positive OBI were significantly associated with positive anti-HBc antibodies and late histological grades (3-4). Multivariate logistic regression analysis revealed that the presence of OBI was a predictor of more advanced HCC histological grades in patients with HCV infection. CONCLUSION: OBI was detected in 50% of HCV-infected patients with HCC. OBI was strongly associated with the presence of anti-HBc antibodies. Patients with HCC with positive OBI were younger and had more advanced HCC histological grades.


Asunto(s)
Carcinoma Hepatocelular/virología , ADN Viral/sangre , Hepatitis B Crónica/sangre , Hepatitis C Crónica/complicaciones , Neoplasias Hepáticas/virología , Adulto , Distribución por Edad , Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/etiología , Carcinoma Hepatocelular/patología , Estudios de Casos y Controles , Egipto/epidemiología , Femenino , Genotipo , Anticuerpos contra la Hepatitis B/inmunología , Antígenos del Núcleo de la Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/inmunología , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/inmunología , Hepatitis B Crónica/epidemiología , Hepatitis C Crónica/epidemiología , Humanos , Cirrosis Hepática/epidemiología , Cirrosis Hepática/etiología , Cirrosis Hepática/virología , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/etiología , Neoplasias Hepáticas/patología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Estadificación de Neoplasias , Reacción en Cadena de la Polimerasa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...